# NOURIANZ
> **NDA022075** · New Drug Application · Sponsor: KYOWA KIRIN · Approved 2019-08-27
## Drug
- **FDA Application Number:** NDA022075
- **Application type:** New Drug Application
- **Brand name:** NOURIANZ
- **Generic name:** ISTRADEFYLLINE
- **Active ingredients:** ISTRADEFYLLINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** KYOWA KIRIN
- **Manufacturer:** Kyowa Kirin, Inc.
- **First approval:** 2019-08-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022075)
---
*AI Analytics · CC0 1.0*